These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12085235

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 4. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
    Yang C, Klein EA, Assoian RK, Kazanietz MG.
    Biochem J; 2008 Feb 15; 410(1):167-75. PubMed ID: 17941827
    [Abstract] [Full Text] [Related]

  • 5. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M, Grijalva R, Yu D.
    Cancer Res; 1999 Apr 01; 59(7):1620-5. PubMed ID: 10197638
    [Abstract] [Full Text] [Related]

  • 6. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG, Hosick HL, Ethier SP.
    J Cell Physiol; 2000 Jun 01; 183(3):301-13. PubMed ID: 10797304
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM, Yao G.
    J Cell Physiol; 2003 Dec 01; 197(3):326-35. PubMed ID: 14566962
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
    Ding SZ, Smith MF, Goldberg JB.
    J Gastroenterol Hepatol; 2008 Jul 01; 23(7 Pt 2):e67-78. PubMed ID: 18702686
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase.
    Sutter AP, Maaser K, Gerst B, Krahn A, Zeitz M, Scherübl H.
    Biochem Pharmacol; 2004 May 01; 67(9):1701-10. PubMed ID: 15081869
    [Abstract] [Full Text] [Related]

  • 13. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E, Montiel M.
    J Cell Physiol; 2005 Aug 01; 204(2):678-86. PubMed ID: 15744749
    [Abstract] [Full Text] [Related]

  • 14. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
    Greco S, Muscella A, Elia MG, Romano S, Storelli C, Marsigliante S.
    J Cell Physiol; 2004 Oct 01; 201(1):84-96. PubMed ID: 15281091
    [Abstract] [Full Text] [Related]

  • 15. NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways.
    Daly JM, Olayioye MA, Wong AM, Neve R, Lane HA, Maurer FG, Hynes NE.
    Oncogene; 1999 Jun 10; 18(23):3440-51. PubMed ID: 10376522
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C, Lin H, Leonard SS, Shi X, Ye J, Luo J.
    Oncogene; 2003 Aug 14; 22(34):5281-90. PubMed ID: 12917629
    [Abstract] [Full Text] [Related]

  • 17. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
    Nilsson EM, Brokken LJ, Härkönen PL.
    Exp Cell Res; 2010 Mar 10; 316(5):800-12. PubMed ID: 19962979
    [Abstract] [Full Text] [Related]

  • 18. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418
    [Abstract] [Full Text] [Related]

  • 19. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
    Liu TZ, Chen CY, Yiin SJ, Chen CH, Cheng JT, Shih MK, Wang YS, Chern CL.
    Food Chem Toxicol; 2006 Feb 01; 44(2):227-35. PubMed ID: 16112786
    [Abstract] [Full Text] [Related]

  • 20. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
    Léotoing L, Manin M, Monté D, Baron S, Communal Y, Lours C, Veyssière G, Morel L, Beaudoin C.
    J Mol Endocrinol; 2007 Aug 01; 39(2):151-62. PubMed ID: 17693613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.